For: | Heda R, Yazawa M, Shi M, Bhaskaran M, Aloor FZ, Thuluvath PJ, Satapathy SK. Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect. World J Gastroenterol 2021; 27(17): 1864-1882 [PMID: 34007127 DOI: 10.3748/wjg.v27.i17.1864] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i17/1864.htm |
Number | Citing Articles |
1 |
Mihai-Emil Gherghina, Ileana Peride, Mirela Tiglis, Tiberiu Paul Neagu, Andrei Niculae, Ionel Alexandru Checherita. Uric Acid and Oxidative Stress—Relationship with Cardiovascular, Metabolic, and Renal Impairment. International Journal of Molecular Sciences 2022; 23(6): 3188 doi: 10.3390/ijms23063188
|
2 |
Marina V. Maevskaya, Yulia V. Kotovskaya, Vladimir T. Ivashkin, Olga N. Tkacheva, Ekaterina A. Troshina, Marina V. Shestakova, Valeriy V. Breder, Natalia I. Geyvandova, Vladimir L. Doshchitsin, Ekaterina N. Dudinskaya, Ekaterina V. Ershova, Khava B. Kodzoeva, Ksenia A. Komshilova, Natalia V. Korochanskaya, Alexander Yu. Mayorov, Ekaterina E. Mishina, Maria Yu. Nadinskaya, Igor G. Nikitin, Nana V. Pogosova, Aida I. Tarzimanova, Minara Sh. Shamkhalova. The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities. Terapevticheskii arkhiv 2022; 94(2): 216 doi: 10.26442/00403660.2022.02.201363
|
3 |
Rajiv Heda, Alexander J. Kovalic, Sanjaya K. Satapathy. Peritransplant Renal Dysfunction in Liver Transplant Candidates. Clinics in Liver Disease 2022; 26(2): 255 doi: 10.1016/j.cld.2022.01.010
|
4 |
Shiqi Hu, Xiaolan Li, Yuanyuan Sun, Shouling Wu, Yanqi Lan, Shuohua Chen, Yanhong Wang, Wei Liao, Xiaomo Wang, Di Zhang, Xiaojie Yuan, Jingli Gao, Li Wang. Short‐term weight loss decreased the risk of chronic kidney disease in men with incident nonalcoholic fatty liver disease. Obesity 2022; 30(7): 1495 doi: 10.1002/oby.23459
|
5 |
Tingting Qin, Mingliang Wang, Ting Zhang, Yingyu Wang, Yunyun Zhang, Muhammad Hasnat, Zirui Zhuang, Yongfang Ding, Yunru Peng. Total C-21 Steroidal Glycosides From Baishouwu Ameliorate Hepatic and Renal Fibrosis by Regulating IL-1β/MyD88 Inflammation Signaling. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.775730
|
6 |
Jingrui Wang, Zhenzhen Su, Yijin Feng, Ruihan Xi, Jiamin Liu, Peixi Wang. Comparison of several blood lipid-related indexes in the screening of non-alcoholic fatty liver disease in women: a cross-sectional study in the Pearl River Delta region of southern China. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-02072-1
|
7 |
Niki Katsiki, Vasilios Athyros. Serum uric acid: a mediator of cardio-reno-metabolic diseases. Expert Review of Cardiovascular Therapy 2021; 19(12): 1127 doi: 10.1080/14779072.2021.2021071
|